Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo
Not Applicable
- Conditions
- Erythroid Differentiation Regulator 1 (Erdr1) Cytokine
- Registration Number
- NCT03377998
- Lead Sponsor
- Cairo University
- Brief Summary
Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patients with generalized non-segmental vitiligo.
- Both sexes.
- Age >18 years old.
- New cases or cases not receiving any medication for at least 3 months ago.
Exclusion Criteria
- Segmental or Universal vitiligo
- Autoimmune diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo 6 months Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link Erdr1 cytokine expression to vitiligo pathogenesis in skin lesions?
How does Erdr1 cytokine compare to standard-of-care treatments in vitiligo patient outcomes?
Are Erdr1 levels a reliable biomarker for predicting vitiligo progression or treatment response?
What adverse events are associated with Erdr1 modulation in vitiligo clinical studies?
What combination therapies with Erdr1 are being explored for vitiligo treatment by Cairo University or other institutions?